Literature DB >> 17192954

An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD.

Zahoor Syed1, Frank Dudbridge, Lindsey Kent.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common, highly heritable, neurodevelopmental disorder with onset in early childhood. Genes involved in neuronal development and growth are, thus, important etiological candidates and neurotrophic factors have been hypothesized to play a role in the pathogenesis of ADHD. Glial derived neurotrophic factor (GDNF), nerve growth factor (NGF (beta subunit)), and neurotrophic factor 3 (NT3) are members of the neurotrophin family and are involved in the survival, differentiation, and maintenance of neuronal cells. We have examined 10 coding and intronic single nucleotide polymorphisms (SNPs) across GDNF, NGF, and NT3 in a family-based association sample of 120 DSM-IV ADHD probands and their biological parents, as well as a case-control analysis with 120 sex-matched controls. Borderline significant overtransmission of the C allele of a non-synonymous C/T SNP (rs6330) in NGF which codes an alanine/valine change was found in the family-based sample (Chi-square = 3.69, odds ratio (OR) = 1.65, P = 0.05). Although this SNP is located in the 5' pro-NGF sequence and not the mature NGF protein, it may affect intracellular processing and secretion of NGF. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17192954     DOI: 10.1002/ajmg.b.30459

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  15 in total

1.  Association between smoking behaviour and genetic variants of glial cell line-derived neurotrophic factor.

Authors:  Eszter Kotyuk; Nora Nemeth; Zsolt Ronai; Zsolt Demetrovics; Maria Sasvari-Szekely; Anna Szekely
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

Review 2.  Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder.

Authors:  Kerstin Konrad; Simon B Eickhoff
Journal:  Hum Brain Mapp       Date:  2010-06       Impact factor: 5.038

Review 3.  Childhood psychiatric disorders as anomalies in neurodevelopmental trajectories.

Authors:  Philip Shaw; Nitin Gogtay; Judith Rapoport
Journal:  Hum Brain Mapp       Date:  2010-06       Impact factor: 5.038

4.  Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.

Authors:  Ayhan Bilgiç; Aysun Toker; Ümit Işık; İbrahim Kılınç
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-08-25       Impact factor: 4.785

5.  Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation.

Authors:  P Shaw; K Eckstrand; W Sharp; J Blumenthal; J P Lerch; D Greenstein; L Clasen; A Evans; J Giedd; J L Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-16       Impact factor: 11.205

Review 6.  Imaging functional and structural brain connectomics in attention-deficit/hyperactivity disorder.

Authors:  Miao Cao; Ni Shu; Qingjiu Cao; Yufeng Wang; Yong He
Journal:  Mol Neurobiol       Date:  2014-04-05       Impact factor: 5.590

7.  Neuro-glial and systemic mechanisms of pathological responses in rat models of primary blast overpressure compared to "composite" blast.

Authors:  Stanislav I Svetlov; Victor Prima; Olena Glushakova; Artem Svetlov; Daniel R Kirk; Hector Gutierrez; Victor L Serebruany; Kenneth C Curley; Kevin K W Wang; Ronald L Hayes
Journal:  Front Neurol       Date:  2012-02-09       Impact factor: 4.003

8.  Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders.

Authors:  Kathryn J Lester; Thalia C Eley
Journal:  Biol Mood Anxiety Disord       Date:  2013-02-07

9.  Neurotrophic gene polymorphisms and response to psychological therapy.

Authors:  K J Lester; J L Hudson; M Tropeano; C Creswell; D A Collier; A Farmer; H J Lyneham; R M Rapee; T C Eley
Journal:  Transl Psychiatry       Date:  2012-05-01       Impact factor: 6.222

10.  Nerve growth factor and its receptor in schizophrenia.

Authors:  Roksana Zakharyan; Sofi Atshemyan; Anaida Gevorgyan; Anna Boyajyan
Journal:  BBA Clin       Date:  2014-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.